Pub. Date : 2016 May
PMID : 26865218
7 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | METHODS AND RESULTS: Coadministration of quercetin and valinomycin (50 muM quercetin/0.05 muM valinomycin) reduced intracellular reactive oxygen species content and increased cell viability (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) of Caco-2 cells compared to valinomycin-only (0.05 muM) treatment. | Valinomycin | latexin | Homo sapiens |
| 2 | METHODS AND RESULTS: Coadministration of quercetin and valinomycin (50 muM quercetin/0.05 muM valinomycin) reduced intracellular reactive oxygen species content and increased cell viability (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) of Caco-2 cells compared to valinomycin-only (0.05 muM) treatment. | Valinomycin | latexin | Homo sapiens |
| 3 | METHODS AND RESULTS: Coadministration of quercetin and valinomycin (50 muM quercetin/0.05 muM valinomycin) reduced intracellular reactive oxygen species content and increased cell viability (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) of Caco-2 cells compared to valinomycin-only (0.05 muM) treatment. | Valinomycin | latexin | Homo sapiens |
| 4 | METHODS AND RESULTS: Coadministration of quercetin and valinomycin (50 muM quercetin/0.05 muM valinomycin) reduced intracellular reactive oxygen species content and increased cell viability (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) of Caco-2 cells compared to valinomycin-only (0.05 muM) treatment. | Valinomycin | latexin | Homo sapiens |
| 5 | METHODS AND RESULTS: Coadministration of quercetin and valinomycin (50 muM quercetin/0.05 muM valinomycin) reduced intracellular reactive oxygen species content and increased cell viability (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) of Caco-2 cells compared to valinomycin-only (0.05 muM) treatment. | Valinomycin | latexin | Homo sapiens |
| 6 | METHODS AND RESULTS: Coadministration of quercetin and valinomycin (50 muM quercetin/0.05 muM valinomycin) reduced intracellular reactive oxygen species content and increased cell viability (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) of Caco-2 cells compared to valinomycin-only (0.05 muM) treatment. | Valinomycin | latexin | Homo sapiens |
| 7 | METHODS AND RESULTS: Coadministration of quercetin and valinomycin (50 muM quercetin/0.05 muM valinomycin) reduced intracellular reactive oxygen species content and increased cell viability (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) of Caco-2 cells compared to valinomycin-only (0.05 muM) treatment. | Valinomycin | latexin | Homo sapiens |